KKR buys Japanese drugmaker Bushu Pharmaceuticals from BPEA EQT

US private equity heavyweight KKR has acquired all shares in Japan-based drug contract manufacturer Bushu Pharmaceuticals from pan-Asian private equity firm Baring Private Equity Asia, which is owned by EQT AB.